Multiplex tandem mass spectrometry enzymatic activity assay for the screening and diagnosis of Mucolipidosis type II and III.

Abstract

Mucolipidosis type II and III (MLII/III) is caused by defects in the mannose-6-phosphate system, which is essential to target most of the lysosomal hydrolases to the lysosome. MLII/III patients present with marked elevations in the activities of most lysosomal enzymes in plasma, but their profiles in dried blood spots (DBS) have not been well described. In the current study, we measured the activities of 12 lysosomal enzymes in DBS, among which acid sphingomyelinase, iduronate-2-sulfatase, and alpha-N-acetylglucosaminidase were significantly elevated in MLII/III patients when compared to random newborns. This sets the stage for using DBS to diagnose MLII/III. Furthermore, given an increasing number of lysosomal storage disorders are being included in the recommended uniform screening panel, our results also indicate that population-based newborn screening for MLII/III can be implemented with minimal efforts.

• Authors: Xinying Hong, Laura Pollard, Miao He, Michael H Gelb, Timothy C Wood
• Journal: Molecular genetics and metabolism reports (Mol Genet Metab Rep) Vol. 35 Pg. 100978 (Jun 2023) ISSN: 2214-4269 [Print] United States
• PMID: 37275682 (Publication Type: Journal Article)
• Copyright: © 2023 The Authors.